The impact of young age at diagnosis (age & lt;40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis

CONCLUSION: With modern clinical subtyping, age under 40 remains independently associated with worse outcomes in 30 months follow-up only in HR-positive, lower grade disease.PMID:34923225 | DOI:10.1016/j.breast.2021.12.006

Source: Breast - December 19, 2021 Category: Cancer & Oncology Authors: Hee Jeong Kim Seonok Kim Rachel A Freedman Ann H Partridge Source Type: research